These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32307260)

  • 1. Synthesis, state-of-the-art NMR-binding and molecular modeling study of new benzimidazole core derivatives as Pin1 inhibitors: Targeting breast cancer.
    Nashaat S; Henen MA; El-Messery SM; Eisa H
    Bioorg Med Chem; 2020 Jun; 28(11):115495. PubMed ID: 32307260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Benzimidazoles Targeting Breast Cancer: Synthesis, Pin1 Inhibition, 2D NMR Binding, and Computational Studies.
    Nashaat S; Henen MA; El-Messery SM; Eisa H
    Molecules; 2022 Aug; 27(16):. PubMed ID: 36014485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and biological evaluation of benzimidazole derivatives as novel human Pin1 inhibitors.
    Ma T; Huang M; Li A; Zhao F; Li D; Liu D; Zhao L
    Bioorg Med Chem Lett; 2019 Jul; 29(14):1859-1863. PubMed ID: 31103446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-Based Design of Novel Benzimidazole Derivatives as Pin1 Inhibitors.
    Wang S; Guan L; Zang J; Xing K; Zhang J; Liu D; Zhao L
    Molecules; 2019 Mar; 24(7):. PubMed ID: 30934730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and Pin1 inhibitory activity of thiazole derivatives.
    Zhao H; Cui G; Jin J; Chen X; Xu B
    Bioorg Med Chem; 2016 Nov; 24(22):5911-5920. PubMed ID: 27692510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thieno[2,3-d]pyrimidin-4(3H)-one Derivatives of Benzimidazole as Potential Anti- Breast Cancer (MDA-MB-231, MCF-7) Agents.
    Dimov S; Mavrova AT; Yancheva D; Nikolova B; Tsoneva I
    Anticancer Agents Med Chem; 2021; 21(11):1441-1450. PubMed ID: 32698751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and biological evaluation of novel thiazole-based derivatives as human Pin1 inhibitors.
    Du L; Wang X; Cui G; Xu B
    Bioorg Med Chem; 2021 Jan; 29():115878. PubMed ID: 33246256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conjugates of 18β-glycyrrhetinic acid derivatives with 3-(1H-benzo[d]imidazol-2-yl)propanoic acid as Pin1 inhibitors displaying anti-prostate cancer ability.
    Li K; Ma T; Cai J; Huang M; Guo H; Zhou D; Luan S; Yang J; Liu D; Jing Y; Zhao L
    Bioorg Med Chem; 2017 Oct; 25(20):5441-5451. PubMed ID: 28838831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New PIN1 inhibitors identified through a pharmacophore-driven, hierarchical consensus docking strategy.
    Poli G; Di Stefano M; Estevez JA; Minutolo F; Granchi C; Giordano A; Parisi S; Mauceri M; Canzonieri V; Macchia M; Caligiuri I; Tuccinardi T; Rizzolio F
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):145-150. PubMed ID: 34894990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of pyrimidine derivatives as novel human Pin1 inhibitors.
    Cui G; Jin J; Chen H; Cao R; Chen X; Xu B
    Bioorg Med Chem; 2018 May; 26(8):2186-2197. PubMed ID: 29576270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An irreversible inhibitor of peptidyl-prolyl cis/trans isomerase Pin1 and evaluation of cytotoxicity.
    Ieda N; Itoh K; Inoue Y; Izumiya Y; Kawaguchi M; Miyata N; Nakagawa H
    Bioorg Med Chem Lett; 2019 Feb; 29(3):353-356. PubMed ID: 30585173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-guided design of alpha-amino acid-derived Pin1 inhibitors.
    Potter AJ; Ray S; Gueritz L; Nunns CL; Bryant CJ; Scrace SF; Matassova N; Baker L; Dokurno P; Robinson DA; Surgenor AE; Davis B; Murray JB; Richardson CM; Moore JD
    Bioorg Med Chem Lett; 2010 Jan; 20(2):586-90. PubMed ID: 19969456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivo.
    Dubiella C; Pinch BJ; Koikawa K; Zaidman D; Poon E; Manz TD; Nabet B; He S; Resnick E; Rogel A; Langer EM; Daniel CJ; Seo HS; Chen Y; Adelmant G; Sharifzadeh S; Ficarro SB; Jamin Y; Martins da Costa B; Zimmerman MW; Lian X; Kibe S; Kozono S; Doctor ZM; Browne CM; Yang A; Stoler-Barak L; Shah RB; Vangos NE; Geffken EA; Oren R; Koide E; Sidi S; Shulman Z; Wang C; Marto JA; Dhe-Paganon S; Look T; Zhou XZ; Lu KP; Sears RC; Chesler L; Gray NS; London N
    Nat Chem Biol; 2021 Sep; 17(9):954-963. PubMed ID: 33972797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of benzimidazole derivatives as the G9a Histone Methyltransferase inhibitors that induce autophagy and apoptosis of breast cancer cells.
    Zhang J; Yao D; Jiang Y; Huang J; Yang S; Wang J
    Bioorg Chem; 2017 Jun; 72():168-181. PubMed ID: 28460359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and molecular modeling of new benzimidazoles as glutathione S-transferase inhibitors and anticancer agents.
    Abd El-Karim SS; Anwar MM; Zaki ER; Elseginy SA; Nofal ZM
    Future Med Chem; 2018 Jan; 10(2):157-181. PubMed ID: 29235906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re-Evaluating PIN1 as a Therapeutic Target in Oncology Using Neutral Inhibitors and PROTACs.
    Liu C; Chen Z; Chen T; Song H; Shen J; Yuan X; Xia S; Liu Q; Chen Q; Tian Q; Meng X; Han Z; Dong X; Yang Y; Cai L; Cheng X; Jia Y; Liu G; Li J; Ge J; Dou D
    J Med Chem; 2024 Sep; 67(17):15780-15795. PubMed ID: 39229909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors.
    Abdullaziz MA; Abdel-Mohsen HT; El Kerdawy AM; Ragab FAF; Ali MM; Abu-Bakr SM; Girgis AS; El Diwani HI
    Eur J Med Chem; 2017 Aug; 136():315-329. PubMed ID: 28505536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New benzimidazole based hybrids: Synthesis, molecular modeling study and anticancer evaluation as TopoII inhibitors.
    Nawareg NA; Mostafa AS; El-Messery SM; Nasr MNA
    Bioorg Chem; 2022 Oct; 127():106038. PubMed ID: 35870412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational and Structure-Based Development of High Potent Cell-Active Covalent Inhibitor Targeting the Peptidyl-Prolyl Isomerase NIMA-Interacting-1 (Pin1).
    Liu L; Zhu R; Li J; Pei Y; Wang S; Xu P; Wang M; Wen Y; Zhang H; Du D; Ding H; Jiang H; Chen K; Zhou B; Yu L; Luo C
    J Med Chem; 2022 Feb; 65(3):2174-2190. PubMed ID: 35089030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microwave-assisted synthesis of sec/tert-butyl 2-arylbenzimidazoles and their unexpected antiproliferative activity towards ER negative breast cancer cells.
    Abdul Rahim AS; Salhimi SM; Arumugam N; Pin LC; Yee NS; Muttiah NN; Keat WB; Abd Hamid S; Osman H; Mat Ib
    J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1255-60. PubMed ID: 23061895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.